Edition:
India

Harbin Pharmaceutical Group Co Ltd (600664.SS)

600664.SS on Shanghai Stock Exchange

3.98CNY
15 Nov 2018
Change (% chg)

¥0.04 (+1.02%)
Prev Close
¥3.94
Open
¥3.94
Day's High
¥3.99
Day's Low
¥3.90
Volume
20,182,815
Avg. Vol
9,407,085
52-wk High
¥6.00
52-wk Low
¥3.27

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 2,469.71 -0.047
Jun '18 2,776.10 0.088
Mar '18 2,857.83 0.055
FY 2017 Dec '17 2,805.86 0.056
Sep '17 3,043.76 -0.034
Jun '17 3,082.35 0.118
Mar '17 3,085.56 0.018
FY 2016 Dec '16 3,781.68 0.071
Sep '16 3,230.27 0.093
Jun '16 3,663.18 0.113
Mar '16 3,451.76 0.039
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 19.64 30.86 33.64
P/E High - Last 5 Yrs. 69.69 40.52 45.61
P/E Low - Last 5 Yrs. 23.72 23.24 23.70
Beta 0.76 0.89 0.88
Price to Sales (TTM) 1.12 4.02 5.95
Price to Book (MRQ) 2.09 4.77 4.89
Price to Tangible Book (MRQ) 2.28 5.60 6.50
Price to Cash Flow (TTM) -- 22.52 22.90
% Owned Institutions -- 1.13 2.15

Dividends

  Company industry sector
Dividend Yield 8.61 1.59 1.51
Dividend Yield - 5 Year Avg 3.89 1.59 1.52
Dividend 5 Year Growth Rate -- 4.42 5.41
Payout Ratio(TTM) 167.85 46.15 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -15.86 2.23 8.08
Sales (TTM) vs TTM 1 Yr. Ago -4.70 4.64 5.80
Sales - 5 Yr. Growth Rate -4.15 9.65 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago 4.97 19.34 23.27
EPS (TTM) vs TTM 1 Yr. Ago 26.34 -- --
EPS - 5 Yr. Growth Rate -6.05 9.95 10.88
Capital Spending - 5 Yr. Growth Rate -21.55 15.07 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.34 2.20 2.27
Current Ratio (MRQ) 1.59 2.99 3.07
LT Debt to Equity (MRQ) 0.72 10.29 13.15
Total Debt to Equity (MRQ) 17.57 14.52 17.74
Interest Coverage (TTM) -- 41.32 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 26.22 55.21 54.86
Gross Margin - 5 Yr. Avg. 28.19 52.32 52.38
EBITD Margin (TTM) 7.72 -- --
EBITD - 5 Yr. Avg 6.88 18.47 10.90
Operating Margin (TTM) 7.25 14.21 3.24
Operating Margin - 5 Yr. Avg. 3.88 14.35 6.22
Pre-Tax Margin (TTM) 7.86 14.75 4.31
Pre-Tax Margin - 5 Yr. Avg. 4.03 14.80 6.66
Net Profit Margin (TTM) 6.18 10.97 0.58
Net Profit Margin - 5 Yr. Avg. 2.90 11.07 2.90
Effective Tax Rate (TTM) 21.28 23.35 23.26
Effective Tax Rate - 5 Yr. Avg. 28.17 23.63 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) 777,618 905,167,346 803,310,395
Net Income/Employee (TTM) 48,096 106,519,628 94,478,415
Receivable Turnover (TTM) 4.76 5.61 5.78
Inventory Turnover (TTM) 6.18 2.61 3.71
Asset Turnover (TTM) 0.95 0.94 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 5.88 11.33 10.86
Return on Assets - 5 Yr. Avg. 3.08 12.57 11.96
Return on Investment (TTM) 10.39 14.72 14.22
Return on Investment - 5 Yr. Avg. 5.61 16.38 15.54
Return on Equity (TTM) 10.54 16.27 15.99
Return on Equity - 5 Yr. Avg. 5.85 17.46 16.82
  1 Year 3 Year 5 Year
Sales % -10.91 -7.92 -4.15
EPS (TTM) % 33.20 66.09 -6.05
Dividend % -35.00 114.35 --
Note: Units in Millions of US Dollars

Performance for Harbin Pharmaceutical Group Co Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.91%
# of Holders: 35
Total Shares Held: 74,127,808
3 Mo. Net Change: 1,558,454
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 5
# Reduced Positions: 1
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.